We are live on ! Find out more
BCDAW

BioCardia, Inc. Warrant
BCDAW

Delisted

BCDAW was delisted on the 2nd of August, 2024.

Back to rankings

5 hedge funds and large institutions have $641K invested in BioCardia, Inc. Warrant in 2021 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more funds holding

Funds holding: 3 → 5 (+2)

29% less capital invested

Capital invested by funds: $901K → $641K (-$260K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
5
Holders Change
+2
Holders Change %
+66.67%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
+$7.38K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$64
Name Holding Trade Value Shares
Change 		Change in
Stake
CAPTRUST Financial Advisors
1
CAPTRUST Financial Advisors
North Carolina
$555K – – –
Osaic Holdings
2
Osaic Holdings
Arizona
$59K – – –
EAM
3
Empery Asset Management
New York
$20K +$23.8K +18,459 New
Bank of America
4
Bank of America
North Carolina
$6K +$7.38K +5,735 New
UBS Group
5
UBS Group
Switzerland
$1K -$64 -50 -4%

BCDAW Hedge Fund Activity: Q4 2021 in Review

5 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in BioCardia, Inc. Warrant (BCDAW) for Q4 2021, worth a combined $641K — down 29% from $901K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new BCDAW positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Bank of America, opening a new position worth an estimated $7.38K. The largest seller was UBS Group, cutting an estimated $64.

  • 5 institutional investors held BioCardia, Inc. Warrant (BCDAW) as of Q4 2021, up from 3 in Q3 2021.
  • Funds reported $641K of BioCardia, Inc. Warrant stock for Q4 2021, down 29% quarter-over-quarter.
  • 2 funds opened new BioCardia, Inc. Warrant positions in Q4 2021 and 0 closed out, a net change of +2 holders.
  • The largest BioCardia, Inc. Warrant buyer in Q4 2021 was Bank of America, an estimated $7.38K added.
  • The largest BioCardia, Inc. Warrant seller in Q4 2021 was UBS Group, an estimated $64 sold.

Based on aggregated 13F filings for Q4 2021.